Press release
Medullary Thyroid Cancer (MTC) Market is projected to reach USD 1.19 billion by 2034
Medullary Thyroid Cancer
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71235
Medullary thyroid cancer is a rare neuroendocrine malignancy originating from parafollicular C-cells of the thyroid gland. It accounts for ~1-2% of all thyroid cancers, with both sporadic and hereditary forms. The hereditary variant, often linked to RET proto-oncogene mutations, occurs as part of Multiple Endocrine Neoplasia type 2 (MEN2). Early diagnosis and targeted therapy have significantly improved long-term management.
Key Market Highlights
• 2024 Market Size: USD 672 million
• 2034 Forecast: USD 1.19 billion
• CAGR (2025-2034): 5.8%
• Largest Segment: Targeted therapies (RET inhibitors, TKIs)
• Fastest-Growing Segment: Genetic testing & precision oncology
Epidemiology & Clinical Insights
1. Prevalence
• Represents 1-2% of all thyroid malignancies.
• Occurs in both sporadic (~75%) and hereditary (~25%) forms.
• Peak incidence occurs between 40-60 years, though hereditary cases often present earlier.
2. Clinical Characteristics
• Elevated calcitonin levels (biomarker hallmark)
• Diarrhea, flushing (in advanced disease)
• Cervical lymph node involvement
• Metastasis to liver, lungs, and bones in advanced stages
3. Genetic Drivers
• RET mutations dominate both sporadic and hereditary MTC.
• Genetic testing essential for family screening and treatment planning.
4. Diagnosis
• Ultrasound with FNAB
• Serum calcitonin & CEA levels
• CT/MRI/PET imaging
• RET mutation analysis
Market Growth Drivers
1. Expanding Use of RET-Targeted Therapies
Selective RET inhibitors have transformed outcomes for advanced or metastatic MTC.
2. Integration of Precision Oncology
Routine RET testing improves treatment selection and prognosis.
3. Rising Global Thyroid Cancer Incidence
More patients undergoing thyroid screening and biopsy procedures.
4. Minimally Invasive Surgical Advances
Refined thyroidectomy methods reduce morbidity and improve outcomes.
5. Growing Clinical Awareness
Earlier detection due to widespread use of ultrasound and genetic counseling.
Market Restraints
• High cost of targeted therapies
• Limited treatment options for RET-negative tumors
• Adverse effects associated with kinase inhibitors
• Low incidence limits clinical trial scale and R&D investment
Market Opportunities
1. Next-Generation RET Inhibitors
More selective, less toxic molecules under development.
2. Combination Therapy Approaches
RET inhibitors + immunotherapy combinations being explored.
3. AI-Assisted Diagnosis
Automated ultrasound interpretation and risk stratification tools.
4. Liquid Biopsy for Minimal Disease Detection
ctDNA monitoring for recurrence or progression.
5. Screening Programs for MEN2 Families
Growing adoption of prophylactic thyroidectomy in high-risk gene carriers.
Segmentation Overview
By Treatment Type
• Targeted therapies (RET inhibitors, TKIs)
• Surgery (thyroidectomy ± lymph node dissection)
• Radiotherapy
• Chemotherapy (limited role)
• Supportive therapy (management of hormone imbalance, metastases)
By Cancer Type
• Sporadic MTC
• Hereditary MTC (MEN2A, MEN2B, FMTC)
By Route of Administration
• Oral (TKIs, RET inhibitors)
• Intravenous (supportive therapies)
By End User
• Hospitals
• Cancer treatment centers
• Endocrinology clinics
• Genetic counseling centers
Explore Full Report here: https://exactitudeconsultancy.com/reports/71235/medullary-thyroid-cancer-market
Regional Insights
North America - Largest Market
High adoption of advanced targeted therapies, strong genetic testing infrastructure, and robust clinical research.
Europe - Strong Precision Medicine Adoption
Germany, France, Italy, and the UK lead in personalized therapy and MEN2 family screening.
Asia Pacific - Fastest Growing
Increasing thyroid cancer incidence, improving diagnostic tools, and expanding oncology networks.
Latin America - Developing
Growing access to molecular diagnostics and TKI-based therapies.
Middle East & Africa - Emerging
Improving healthcare capacity and adoption of advanced oncology treatments.
Competitive Landscape
Key companies operating in the MTC therapeutics market include:
• Eli Lilly
• Blueprint Medicines
• Genentech / Roche
• Novartis
• AstraZeneca
• Bristol Myers Squibb
• Pfizer
• Merck & Co.
• Exelixis
Focus areas: selective RET inhibition, combination immunotherapy, precision diagnostics, and hereditary cancer screening.
Recent Market Developments
• Expanded approvals for selective RET inhibitors in advanced MTC
• New trials evaluating combination immunotherapy strategies
• Adoption of next-generation sequencing (NGS) panels for thyroid cancer
• AI-powered ultrasound tools improving diagnostic accuracy
• Increased MEN2 screening leading to earlier prophylactic treatment
Future Outlook (2025-2034)
The Medullary Thyroid Cancer Market will grow steadily as:
• Targeted therapies continue to dominate systemic treatment
• Precision medicine expands through routine RET profiling
• Minimally invasive surgery remains a cornerstone for early-stage disease
• Immunotherapy gains momentum in metastatic settings
• Genetic counseling and family screening prevent late-stage diagnosis
By 2034, the market is projected to reach USD 1.19 billion, driven by therapeutic innovation and advances in personalized oncology.
This report is also available in the following languages : Japanese (甲状腺髄様がん市場), Korean (수질성 갑상선암 시장), Chinese (髓样甲状腺癌市场), French (Marché du cancer médullaire de la thyroïde), German (Markt für medulläres Schilddrüsenkarzinom), and Italian (Mercato del cancro midollare della tiroide), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/71235
Our More Reports:
Thyroid Cancer Market
https://exactitudeconsultancy.com/reports/71583/thyroid-cancer-market
Anaplastic Thyroid Cancer (ATC) Market
https://exactitudeconsultancy.com/reports/71630/anaplastic-thyroid-cancer-atc-market
Goitre Market
https://exactitudeconsultancy.com/reports/72019/goitre-market
U.S. Thyroid Test Market
https://exactitudeconsultancy.com/reports/50857/u-s-thyroid-test-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Medullary Thyroid Cancer (MTC) Market is projected to reach USD 1.19 billion by 2034 here
News-ID: 4310923 • Views: …
More Releases from Exactitude Consultancy
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250
Key Market Highlights
• Increasing focus on road maintenance and resurfacing projects
• Growing demand for efficient and precision milling…
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248
Key Market Highlights
• Growing adoption of automated credit risk assessment tools
• Increasing focus on working capital and cash flow management
• Integration…
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246
Key Market Highlights
• Growing adoption of VoIP and…
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244
Key Market Highlights
• Rapid growth of…
More Releases for RET
RET Antibody Market is expected to surpass $12 billion by 2034, with an 8.5% CAG …
The global RET antibody market, valued at approximately $5.2 billion in 2024, is anticipated to expand significantly, with a projected market value of around $12.1 billion by 2034. This growth represents a robust Compound Annual Growth Rate (CAGR) of approximately 8.5% during the forecast period of 2025 to 2034.
Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of…
Electric Bus as a Service (EBaaS) Market Size, Trends 2031 By Key Players- Trans …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Research analysis, the global Electric Bus as a Service (EBaaS) Market size is reached a valuation of USD 1,470.03 Million in 2023, with projections to achieve USD 5,207.57 Million by 2031, demonstrating a 𝐂𝐀𝐆𝐑 19.80% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏.
What is the outlook of the Electric Bus as a Service (EBaaS) market in the coming years?
The Electric Bus as a Service (EBaaS) market is…
Ret antibody Market Size, Demands, Growth Dynamics, Top Company, and Global Fore …
The Ret antibody market is a growing segment within the global biotechnology and pharmaceutical industries, driven by the increasing prevalence of cancers associated with RET gene mutations, such as thyroid and non-small cell lung cancer. RET (Rearranged during Transfection) is a proto-oncogene that plays a crucial role in cellular growth and differentiation. Mutations in the RET gene can lead to uncontrolled cell proliferation, making it a significant target for therapeutic…
Unlock Radiant Skin: Usmedilife Now Offers A-Ret Gel 0.05 (20gm) for Acne and An …
London, United Kingdom - In a world where skincare is paramount, finding a reliable source for effective solutions can make all the difference. Usmedilife Pharmacy is proud to announce the availability of A-Ret Gel 0.05 (20gm) in the United Kingdom, providing residents with a powerful skincare solution to combat acne, reduce signs of aging, and promote overall skin health.
The Power of A-Ret Gel 0.05: A Skincare Game-Changer
1. Tackling Acne with…
Remote Electrical Tilt (RET) Control Cables Market Research Report 2023
Remote Electrical Tilt (RET) Control Cables Market
The global Remote Electrical Tilt (RET) Control Cables market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-9S11469/Global_Remote_Electrical_Tilt_RET_Control_Cables_Market_Research_Report_2022
North American market for Remote Electrical Tilt (RET) Control Cables is estimated to…
Auto Parts Store Software Market to Observe Prominent Growth of USD 4,733.73 Mn- …
The latest research on "Auto Parts Store Software Report 2023" offered by MRA provides a comprehensive investigation into the geographical landscape, industry size along with the revenue estimation of the business. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the "Market".
The global Auto Parts Store Software market size was valued at USD 12.90 billion in 2022 and is anticipated to…
